Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

This study evaluated potential of serum tumor markers to predict the incidence and intensity of pancreatic cancer metastasis as well as patient survival. Retrospective records from 905 patients and prospective data from 142 patients were collected from two high-volume institutions. The levels of eig...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liang, Xu, Hua-Xiang, Wang, Wen-Quan, Wu, Chun-Tao, Xiang, Jin-Feng, Liu, Chen, Long, Jiang, Xu, Jin, Fu, De-Liang, Ni, Quan-Xing, Houchen, Courtney W., Postier, Russell G., Li, Min, Yu, Xian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868732/
https://www.ncbi.nlm.nih.gov/pubmed/26745601
http://dx.doi.org/10.18632/oncotarget.6819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868732/
https://www.ncbi.nlm.nih.gov/pubmed/26745601
http://dx.doi.org/10.18632/oncotarget.6819

Ejemplares similares